CAS enables AI success

Our high-quality data and deep science expertise maximize the power of predictive models to drive innovation.
See how

CAS and Cleveland Clinic collaborate to accelerate brain health and Alzheimer’s research

Leading organizations unite data, advanced AI, and quantum computing capabilities to progress discovery to improve lives.
Learn more

Explore the new CAS BioFinder Discovery Platform

Move your drug discovery program through each phase quickly with access to life sciences data and a new solution.
Learn more

Innovate faster with CAS SciFinder

Accelerate discovery using the world’s most trusted source of scientific knowledge.
Explore CAS SciFinder

Cultivating critical biomaterial trends from scientific literature

Focusing on cutting-edge scientific research, Westlake University sought to partner with an organization rich in scientific knowledge expertise and state-of-the-art data analytics capabilities.

Read the case study
Left arrow
Right arrow
Two hexagons connected by a yellow intersect
CAS Data

Curated scientific knowledge to power discovery

High-quality data is the lifeblood of today’s digital R&D pipeline. Every day, our scientists curate, connect, and analyze the valuable data disclosed in scientific publications from around the world to build the CAS Content Collection™, covering over 150 years of discoveries.

Our data underpins all CAS Solutions and can be licensed for machine learning or in-house workflow integration. Our scientists also support custom data curation projects through CAS Custom Services.

Discover more

Latest from CAS Insights™

Emerging Science

Nobel Prize winners

Discover how Nobel-winning science unfolds—from breakthrough ideas to global recognition. CAS Insights reveals the context, challenges, and impact behind these discoveries.
|Article
Read article
Drug Discovery

Theranostics: How nuclear medicine is changing precision oncology

Nuclear medicine's theranostics approach enables "see it, treat it" cancer therapy using the same agents for diagnosis and treatment. Investment tripled to $14.86B in 2024 as these precision treatments move to early-stage care.
|Article
Read article
Biotechnology

From batteries to biosensors: Conductive polymers make the jump to commercial applications

Revolutionary materials that conduct electricity like metals while bending like plastics are transforming everything from batteries to brain implants. Discover how conductive polymers went from Nobel Prize discovery to cutting-edge biomedical breakthroughs.
|Article
Read article
View all CAS Insights